Infectious bursal disease (Gumboro) virus causes immunosuppression in chickens, increasing 19 their susceptibility to other viral and bacterial diseases and resulting in vaccination failure. In the 20 present study, we investigated the immune-depressing effect of infectious bursal disease virus on 21 H9N2 avian influenza viral infection in commercial broiler chickens. Chickens were divided into 22 four groups. In group A, chickens were inoculated with Gumboro virus at 21 days of age and 23 H9N2 influenza virus 5 days later. Groups B and C only received influenza virus at 26 days of 2 24 age and Gumboro virus at 21 days, respectively. Chickens in the control group (D) were 25 inoculated with normal saline at the same times. 26 Tissue samples from different organs were collected on days 1, 3, 6, 9, and 12 after H9N2 27 infection. Macroscopic observation showed bursal disease lesions in groups A and C, including 28 swollen bursa with the presence of gelatinous exudates, hemorrhages in the thigh muscle, edema, 29 and nephritis. 30 Reverse transcription polymerase chain reaction was used to study H 9 N 2 influenza virus 31 dissemination, and quantitative reverse transcription polymerase chain reaction to determine 32 viral genome copy number in different organs. A considerable titer of avian influenza virus was 33 found in the trachea, lungs, cecal tonsils, spleens, and feces of infected chickens. The genome 34 copy number of the virus in the trachea and lungs of group A was significantly higher than that 35 in group B on the first day after inoculation. However, our method did not detect the avian 36 influenza virus genome in group A. In conclusion, we suggest that pre-exposure to Gumboro
Introduction 41 Infectious bursal disease virus (IBDV) is a member of the Birnaviridae family, which has 42 double-stranded RNA genomes. The virus results in acute, highly contagious infections, 43 immunosuppression, and mortality in young chickens [1, 2] , and related economic losses to 44 chicken farms are substantial. Bursal damage is the main feature of the disease (IBD or 45 Gumboro) and is observed in affected chickens worldwide [1] . In IBD, immunosuppression 46 increases susceptibility to other viral diseases, such as viral arthritis [3], Marek's disease [1] , 47 infectious bronchitis [4], infectious laryngotracheitis [5] , inclusion body hepatitis [6] , and 48 chicken infectious anemia [7] , as well as infection by protozoa [8] . 49 The H 9 N 2 avian influenza virus (AIV) is a pathotype of low pathogenic avian influenza (LPAI) 50 virus in broiler chickens [9] and has been reported in Asia, especially in the middle east [10, 11] . 51 Subtypes of this virus are now known to be enzootic in rural areas of Iran and present in 52 commercial chicken farms. Although H 9 N 2 AIV is an LPAI virus, it has severe pathogenicity and 53 causes a high mortality rate among farm chickens co-infected with other bacterial and viral 54 diseases [9, 12] . As IBDV is involved in many such co-infections, a greater degree of influenza 55 viral replication is expected in IBDV-infected chickens. To determine to what extent IBDV 56 affects sequela of H 9 N 2 infection, we studied the effects of IBDV inoculation on subsequent 57 H 9 N 2 AIV infection in 215 broiler chicken, in term of clinical signs, gross pathology, serology, 58 virus dissemination in different organs, and shedding of the virus from trachea as well as in the 59 feces. regarding standards for the protection of animals used for experimental purposes. To determine 71 maternal immunity ten 3-day-old chickens were randomly selected and euthanized. Blood 72 samples were then collected and tested for serum antibodies against IBDV and H 9 N 2 AIV using 73 ELISA and hemagglutination inhibition (HI), respectively. by RT-PCR to look for AIV contamination. In addition, serum samples were collected from both 94 groups and tested by HI to confirm the RT-PCR results of AIV contamination. 95 On day 5 after inoculation, chickens in the treatment group were assigned to subgroup A (70 96 chickens) or C (25 chickens), and chickens in the control group were divided into subgroups B 97 (70 chicken) and D (25 chickens). In the AIV inoculation step, each group was transferred into a 98 separate, isolated room. Chicken in subgroups A and B were then intranasally inoculated with 99 10 6.5 EID 50 /0.1 ml of A/Chicken/Iran/772/1998(H 9 N 2 ) AIV, and subgroups C and D received 100 sterile saline only. 101 The chickens were observed for any clinical signs of avian influenza (AI) twice daily. In each 102 subgroup, five chickens were randomly selected and euthanized 1, 3, 6, 9, and 12 days post-103 inoculation (dpi). Tissue samples from the trachea, lungs, brains, spleens, cecal tonsils, and feces 104 were then isolated and preserved at -80°C until analyzed. In addition, blood samples were 105 collected from each subgroup and tested for antibodies against influenza virus by an HI assay. To 106 trace the possible H 9 N 2 viremia in chickens from subgroups A and B, samples were collected 107 from 5 euthanized chickens every 8 h for 3 dpi. Buffy coats were isolated from the blood 108 samples and tested for the presence and quantity of virus using RT-PCR. 109 110 RNA extraction 111 Total RNA in the buffy coat samples was isolated using a Cinnapure RNA kit (CinnaGen 112 Molecular Biology and Diagnostic, Tehran, Iran) according to the manufacturer's instructions. 113 Briefly, 400 µl of lysis buffer was added to 100 µl of the sample, and the solution was mixed. 114 Then, 300 µl of precipitant solution was added, and the solution was mixed again. A total 115 volume of 800 µl of solution was transferred into the included column and centrifuged at 12000 6 116 rpm for 15 min. The columns were washed twice with the washing buffer. Total RNA was 117 dissolved in 30 µl of RNase-free water via centrifugation and stored at -70 o C. 118 Tissue and fecal samples were prepared for RNA extraction using RNX-plus solution 119 (CinnaGen). Briefly, a 10% (W/V) suspension of feces was prepared in DEPC water and 120 centrifuged at 250 g for 10 min at 4°C. The supernatant was removed, and tissues weighing 50-121 100 mg were then homogenized in RNX-plus. RNA was isolated according to the manufacturer's 122 protocol. All RNA samples were normalized to the lowest concentration in DNase-/RNase-free 123 distilled water before quantitation. The mean titers of antibodies after H 9 N 2 inoculation are presented in were isolated from five chicks in each group and subjected to RT-PCR analyses using VP 2 gene 226 primers 3 days after IBDV inoculation. The results showed a 743 bp amplicon, whereas group II, 227 was negative for IBDV infection. All tested samples were negative for AIV infection at this 228 point. 229 On 1, 3, 6, 9, and 12 dpi with AIV, 5 chickens from each subgroup were euthanized, and their 230 spleens, trachea, cecal tonsils, lungs, brains, and feces were isolated and tested for H 9 N 2 using 231 RT-PCR. Blood samples were isolated at 8 h intervals and tested up to 3 days after influenza 232 infection. The results were negative in subgroups C & D (Table 3 ). In subgroups A and B, H 9 N 2 233 was not detected in buffy coat samples. Table 3 . by maternal antibodies, immunosuppression by IBDV is a rare occurrence. In the present study, 252 the chickens were inoculated at 21 days. Therefore, we did not expect the immunosuppressive 253 effect of IBDV to be very strong. However, our results showed that HI antibody titer was lower 254 in subgroup A (treated with IBDV) than in subgroup B on day 12 after AIV infection, which may 255 be due to IBDV immunosuppression or lower AIV replication. 256 In this study, no AIV shedding was observed in subgroup A except at 1 dpi. In subgroup B, in 
